Next Article in Journal
Effect of Penetration Enhancers as Cosurfactants on Transdermal Delivery of Caffeine and Using Microemulsions
Previous Article in Journal
A Decade of Innovation: Medicinal Products with New Active Substances Centrally Authorized Within the EU Between 2011 and 2020
Previous Article in Special Issue
Process for Avidin Recovery from Egg White by Pseudo-Affinity Chromatography
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Perspective

Advances in the Purification of Lactoferrin and Lactoperoxidase from Dairy Whey

by
María F. Baieli
1,2,*,
Laura D. Pilato
1,2,
María V. Miranda
1,2 and
Federico J. Wolman
1,2
1
Facultad de Farmacia y Bioquímica, Universidad de Buenos Aires, Junín 956, Buenos Aires C1113AAD, Argentina
2
Instituto de Nanobiotecnología (NANOBIOTEC), Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET), Universidad de Buenos Aires, Junín 956, Buenos Aires C1113AAD, Argentina
*
Author to whom correspondence should be addressed.
J. Pharm. BioTech Ind. 2026, 3(3), 16; https://doi.org/10.3390/jpbi3030016
Submission received: 27 May 2026 / Revised: 2 July 2026 / Accepted: 6 July 2026 / Published: 8 July 2026

Abstract

The development of strategies and processes to valorize cheese whey is an area of constant advancement and growth, primarily due to the large volume generated daily and inherent technical difficulties in cost-effectively processing this material. In this regard, the present perspective will discuss and analyze different strategies based on chromatographic innovations to develop processes that enable the direct and selective capture and purification of bovine lactoferrin (LF) and lactoperoxidase (LP) proteins from cheese whey. These proteins possess interesting commercial value and represent minor components of the whey protein fraction, with whey being their main source. Given that this issue is dedicated to the memory and career of Prof. Dr. Osvaldo Cascone, and considering his extensive research in this area, his contributions will be examined chronologically to illustrate the strategic technological advancements made by his research group. Specifically, the advancements achieved in terms of efficiency in the selectivity and purity obtained for the target proteins through the development of affinity chromatographic matrices and processes will be discussed, as well as the progress made in terms of whey processability.

1. Introduction

Whey is a primary by-product resulting from the manufacture of cheese, casein, and yogurt. The type of whey produced depends on the method used for casein precipitation [1]. Sweet whey is the most common type, produced when casein is precipitated with rennet at a pH of 6.5 during the making of semi-hard and hard cheeses. Acid whey is a by-product of cream cheese, quark, paneer, and Greek yogurt manufacture, resulting from casein precipitation using lactic acid or mineral acids at a pH of 4.6. Whey is often considered a waste product despite its rich composition of valuable biomolecules [1]. Historically, a significant portion of whey was discarded, leading to environmental concerns. However, recognition of the nutritional and functional properties of whey proteins has led to increasing efforts in their valorization [2]. Whey contains a complex mixture of proteins that require isolation and purification to fully exploit their nutritional and functional characteristics. The subsequent fractionation of these proteins yields valuable ingredients that are used in many important food and pharmaceutical applications [1,3,4]. Moreover, whey serves as an excellent model mixture for investigating the chromatographic separation of proteins [5].
Whey contains approximately 50% of milk solids and 20% of the total proteins from milk, serving as a source of lactose, proteins, vitamins, and dairy minerals [1,6]. Lactose constitutes over 70% of the total dry matter in whey, whereas proteins make up 7.5–14%. The main protein components are β-lactoglobulin (BLG, 40–50% w/w, α-lactalbumin (ALA, 12–15% w/w), and glycomacropeptide (GMP, 12% w/w, present only in rennet whey). Minor proteins and peptides include immunoglobulins (Igs, 8.0% w/w), bovine serum albumin (BSA, 5.0% w/w), lactoferrin (1.0% w/w), lactoperoxidase (0.5% w/w), and proteose-peptone [1]. Whey proteins are considered one of the most valuable food proteins available due to their richness in all essential amino acids, which are integral to human health, and their unique functional and nutraceutical properties [7]. Proteins like BLG are used as emulsifiers and foaming and gelling agents. ALA, as another example, is a component in infant formula and has antimicrobial and antiulcer properties.
Historically, untreated whey was a waste product with a high organic load. Currently, strict environmental regulations limit its disposal, making its valorization necessary. Modern use focuses on biological/chemical conversion (e.g., biogas or ethanol) and, most importantly, fractionation of its components. Fractionation, typically involving ultrafiltration, leads to the recovery and concentration of whey proteins into high-value ingredients such as Whey Protein Concentrate (WPC, up to 80% protein), Whey Protein Isolate (WPI, up to 90% protein), and pure proteins. Among these, LF and LP have garnered significant attention due to their diverse biological activities [5,7,8].
Lactoferrin is a glycoprotein found in external secretions in mammals with iron-chelating capacity and with antimicrobial, antiviral, anti-inflammatory, and immunomodulatory properties [9]. In addition, abnormal levels of LF in the human body have been implicated in serious diseases like inflammatory bowel disease, Alzheimer’s disease, and dry eye disease [9]. Recent studies suggest that LF can be used as a biomarker for the diagnosis of various diseases. LF has a molecular weight of around 80 kDa and a basic isoelectric point (pI) of approximately 8.0. Its concentration in sweet whey is typically low, around 0.08–0.20 g/L [10,11]. LF has considerable commercial value due to its potential applications in the food, pharmaceutical, and cosmetic industries [6]. Consequently, the isolation and purification of LF from whey are important goals [12].
Lactoperoxidase is also a glycoprotein present in milk, whey, and colostrum. The molecular weight of LP is similar to that of LF, approximately 78 kDa, and it has a high pI of approximately 9.6. Its concentration in sweet whey is also low, about 0.03–0.06 g/L [11,13]. LP is an enzyme that belongs to the lactoperoxidase system and has potent antimicrobial activity, making it valuable in various areas like food, cosmetics, pharmaceuticals, veterinary medicine, and agriculture [2,8]. LP oxidizes certain substances, like SCN-, in the presence of hydrogen peroxide to form strong antimicrobial substances. LP plays a significant role in protecting the lactating mammary gland and intestinal tract of newborn infants against pathogenic microorganisms. Also, LP has been implicated in the degradation of various carcinogens and in protecting animal cells against peroxidative effects. Because of its value, studies focus on the efficient separation and optimization of LP recovery, often investigating its separation concurrently with lactoferrin, using techniques like ion-exchange chromatography [8,12].
The isolation and purification of these valuable proteins from the complex matrix of cheese whey remain a challenge, demanding the development of efficient and cost-effective purification strategies [14,15].
Scaling up laboratory-developed purification protocols to industrial levels presents the following practical challenges [16]:
  • Cost-effectiveness: minimizing the cost of adsorbents, reagents, and energy;
  • Process efficiency: achieving high yields and purity while maintaining high throughput;
  • Fouling: the problem of non-specific binding and fouling of membranes or resins by other whey components, which can reduce life and efficiency;
  • Protein stability: maintaining the biological activity and integrity of whey proteins throughout the purification process.

2. Whey Protein Purification

Extensive pre-treatments, such as centrifugation, precipitation, calcium chelation, and/or filtration, are typically used in the traditional methods for separating high-value proteins from milk or whey to eliminate residual fat and caseins [6,17]. Even though these pre-treatments are shown to be efficient steps, they can lead to a drop in protein yield or activity, which ends up making the process more expensive and complicated. Therefore, the development of more effective and straightforward techniques for capturing these proteins is highly important [6,17].
Chromatography plays a pivotal role in the downstream processing of proteins, offering high selectivity and resolution. Whey proteins have been purified using a variety of chromatographic methods, such as affinity chromatography, size exclusion chromatography, hydrophobic interaction chromatography, and ion exchange chromatography [14,15,18,19,20,21,22,23,24,25].
Ion exchange chromatography, a fundamental technique, is widely used because of its ability to separate proteins based on their charge, which is highly dependent on medium pH. It is often employed for the purification of major whey proteins and can also be adapted for the minor proteins [16]. A critical challenge when processing raw milk is the presence of fat and casein, which can clog chromatographic columns and lead to excessive backpressure [17]. It was demonstrated that maintaining the processing temperature around milking temperature (35−37 °C) is crucial to prevent fat solidification and minimize fouling, allowing significant quantities of raw milk to pass through the column without exceeding the maximum allowable backpressure [17]. The choice of chromatographic resin is paramount. The particle size of the resin influences both the adsorption kinetics and allowable flow rates/backpressure. Larger beads, like those in SP Sepharose Big Beads, generally offer lower backpressure, which is advantageous for processing viscous and particle-laden raw materials [17]. Pioneering work in chromatographic techniques, particularly cation exchange chromatography, has shown promise for the direct capture of LF and LP from milk or whey [6,17]. Fee and Chand (2005) [17] developed two ion exchange chromatography methods for the direct purification of proteins from unprocessed whole milk immediately after milking. The first approach utilized a single-stage batch process with two types of cation exchangers: SP Sepharose Big Beads (average diameter 155 µm) and SP Sepharose Fast Flow (average diameter 90 µm). The second method employed a packed column specifically using SP Sepharose Big Beads, which, due to their large particle diameter, allow for operation at significantly lower column backpressures. Unlike traditional techniques, both methods leverage the natural temperature of the milk as it leaves the animal (35–37 °C). This strategic temperature control prevents milk fat from solidifying and blocking the system while simultaneously favoring faster adsorption kinetics. By using raw whole milk directly from the farm, these processes eliminate the need for extensive pre-treatments to remove fat and caseins. The authors concluded that these robust and rapid techniques are ideal for on-farm implementation, as they avoid the loss of protein activity associated with conventional steps and do not significantly alter the macroscopic properties of milk. Therefore, this innovative approach aims to bypass the pre-treatment steps, simplifying the purification process, reducing operational costs, and potentially increasing the overall yield and purity of the target proteins. The ability to directly process raw milk or whey for the isolation of these valuable proteins opens up new possibilities for on-farm processing and enhances the sustainability of dairy operations [6].
Affinity chromatography stands out due to its highly specific interaction between a target molecule and a complementary ligand immobilized on a stationary phase [26]. It is a desirable choice for complex biological mixtures like whey because of its specificity, which frequently results in high purity and recovery in a single step. However, the nature of the ligand often limits the applications of this technology to be used only in products of very high commercial value. In this context, dye-affinity chromatography has become a viable and affordable substitute for traditional affinity ligands. Through a combination of ionic, hydrophobic, and hydrogen bonding interactions, textile dyes, often triazine-based, can mimic natural ligands and bind to a variety of proteins, including LF and LP.
The choice of the support for ligand immobilization is also crucial because it affects how much can be adsorbed, the hydrodynamic characteristics, how productive the process is, and the overall efficiency of purification [24,27]. Membrane chromatography is a promising technology that offers faster processing and lower pressure drops compared to packed columns. This can be especially useful for large-scale processing of whey [16,28,29].
On the other hand, the batch process, using adequate diffusive resins, is highly suitable for scalability implementation due to its simplicity, effective protein extraction in a single step, and potential for batch traceability. One of the main benefits of batch purification is that raw, untreated milk can be directly processed [17].

3. Purification of Lactoferrin and Lactoperoxidase

Traditionally, a variety of chromatographic techniques, such as hydrophobic interaction, ion exchange, and affinity chromatography, have been used to purify LF from natural sources such as milk, whey, and colostrum [24]. Methods for LP purification include ion exchange and affinity chromatography [25].
Ion exchange is mainly used in large-scale processes, based on LF and LP pI [24]. However, processing becomes more difficult due to the low concentration of both proteins in cheese whey, which frequently necessitates conditioning and concentration of the starting material to increase the yield of the chromatographic process. These processes achieve yields between 50 and 96%, and LF is often co-purified with LP [24]. Examples of co-purification include yields of 73% for LP and 50% for LF using commercial sulfonic membrane adsorbent [30] and a yield of 84% for LF and 10% of the initial LP content purified from a sweet whey concentrate using a similar cation exchange system [31].
Similarly, ion exchange processes achieve variable LP yields between 40 and 90% and are often co-purified with significant levels of LF [25]. Interestingly, when attempting to purify both proteins by applying a sequential or gradient elution using this technique, LP is reported to elute first, followed by LF. This behavior contradicts expectations based on their respective pI. Given its higher pI, LP would theoretically be expected to elute after LF. However, its greater surface hydrophobicity and lower effective charge density relative to LF cause it to elute earlier from the column [8].
As was previously mentioned, triazine dye affinity chromatography is a cost-effective approach. These dyes are low-cost pseudo-bio affinity ligands and are widely used for chromatography. They are easy to immobilize on different supports and are chemically and thermally stable [27]. All these advantages make them suitable for protein purification on an industrial scale.
Over the years, the research group led by Dr. Osvaldo Cascone has made significant contributions to the development of chromatographic strategies for the valorization of dairy byproducts. Their studies have focused primarily on optimizing the purification processes of high-value proteins, such as LF and LP, using diverse chromatographic matrices ranging from commercial Sepharose supports and hollow fiber membranes to innovative biopolymers like chitosan mini-spheres. Table 1 presents a chronological summary of the results, detailing the matrices used and the efficiency parameters achieved for each target protein.

3.1. Triazine Dye Chromatography

Since 1996, our group, headed by Dr. Cascone, has been dedicated to the development of efficient LF and LP purification processes using dye-affinity chromatography, moving beyond traditional column chromatography [30].

3.1.1. Membrane-Based Supports

In the initial stage of this research, which is detailed below, eight triazine dyes immobilized on Sepharose were tested, and it was demonstrated that the triazine dye Red HE-3B exhibited acceptable chromatographic performance for the direct purification of LF from colostrum and sweet whey. In those years, direct processing of raw samples was not entirely feasible with most common commercial chromatographic materials, and it often required some pretreatment to improve processability. Chromatographic purification of LF using ion-exchange processes usually requires a preconcentration step to increase the protein concentration and prevent leaching during whey capture [35]. Its low concentration and the high solute load present in whey hindered its direct capture and purification. From this perspective, dyes, as low-cost ligands, showed their ability to efficiently adsorb LF without significant losses in the percolates, enabling, in turn, its subsequent effective desorption.
Given the large volumes of whey required to produce marketable quantities of LF, membrane-based support appears to be a suitable choice for industrial-scale operations. In these membrane-based adsorptive systems, solute transport limitations are significantly reduced, allowing high-speed chromatographic processing [31,36,37]. In these systems, the accessibility of the target protein to the adsorptive surface is not limited by molecular diffusion phenomena, as occurs in particulate or gel-based chromatography. Instead, the convective flow itself transports the protein to the active sites of the matrix. From a theoretical perspective, the flow rate does not affect the adsorptive capacity of these chromatographic materials, thus enabling high-speed processes. However, a significant limitation of these systems used to be their low adsorptive capacity. To overcome this limitation and enhance the productivity of the membrane system used, the strategy implemented in our work focused on increasing the available surface area by grafting acrylic copolymer blends prior to dye immobilization [31]. By employing a direct gamma radiation grafting process with equal proportions of glycidyl methacrylate (GMA) and dimethyl acrylamide (DMAA) monomers, the adsorptive capacity of the material was significantly enhanced compared to that achieved using GMA alone. In this sense, productivity can be defined as the mass of purified protein per unit of matrix volume per unit of processing time, and the quantity of purified protein is contingent upon the efficiency of the adsorption and elution steps. Therefore, by increasing the adsorptive capacity, the productivity of the system can be increased. On the other hand, hollow fibers were selected as the best-suited membrane configuration for processing raw material samples such as those of the dairy industry. The membranes used (polysulfone hollow-fiber microfiltration membranes, GE Healthcare Bio-Sciences) featured an internal surface of 15 m2/g, a nominal internal pore diameter of 0.65 µm, and a nominal porosity of 80%. As mentioned, hollow fibers were synthesized by grafting a glycidyl methacrylate/dimethyl acrylamide copolymer onto the polysulfone membranes, followed by the immobilization of Red HE-3B dye. This innovative approach exhibited a significantly higher maximum LF adsorption capacity (111 mg LF/mL membrane) than that obtained with the same ligand immobilized on agarose beads (9.3 mg/mL) (Figure 1). The cartridge assembled with these membranes, operated at a flow rate of 5 mL/min, achieved a productivity of 501.5 µg/h×mL (Figure 1). This represents a 500% increase compared to the Sepharose matrix, which yielded 82.8 µg/h×mL at a flow rate of 0.4 mL/min (Figure 2), which was the highest flow allowed to avoid resin compression. Furthermore, when tested with colostrum in a batch system, the dye-membranes adsorbed 91% of the LF, compared to 56% adsorbed by dye-agarose beads. Optimal desorption was achieved with 2 M NaCl in 25% ethylene glycol, indicating the strong binding nature and efficient recovery potential of this membrane system. The LF purification yield was 90.1% for the membranes and 44.8% for beads. A purity of 94% was reached in a single step using the dyed membranes, with casein and immunoglobulin as the only remaining contaminants. Despite its high performance and purity, the system encountered scale-up challenges. These were likely due to the membrane’s pore size and solute concentration polarization effects, which hindered the system’s viability at larger operational scales. The system allowed the efficient processing of a relative volume of 20 column volumes; however, attempts to process larger volumes were unsuccessful due to the increased system pressure and the significant reduction in the filtration rate.

3.1.2. Particle-Based Supports

As mentioned, a Sepharose matrix functionalized with eight different triazine dyes as ligands was previously evaluated for the affinity chromatography purification of LF from rennet whey [30]. While three of the dyes showed no adsorption across the pH range tested, the remaining five adsorbed varying amounts of LF depending on the pH of whey. Based on gradient elution data, a batch purification technique was developed using Red HE-3B as an affinity ligand, immobilized on the agarose-based matrix. The optimized procedure achieved an 82% recovery of the LF content with a high purity of about 90%.
An advantage of using triazine dyes as ligands is that expanding the number of dyes evaluated during the screening process increases the likelihood of identifying superior ligands for a target protein. Consequently, a new screening revealed that the previously untested Yellow HE-4R dye showed similar performance to Red HE-3B. Therefore, a comparative study was conducted using commercial Sepharose 4B resins as the initial chromatographic support. The density of the dyes immobilized in the Sepharose 4B matrix was 1.46 ± 0.02 µmol/g for Red HE-3B and 2.27 ± 0.14 µmol/g for Yellow HE-4R. Adsorption isotherm analysis showed that the Yellow HE-4R immobilized on Sepharose 4B (S-Y matrix) had a higher maximum capacity (Qmax = 40.24 mg/g) than the Red HE-3B immobilized on Sepharose 4B (S-R matrix) (Qmax = 27.82 mg/g). The matrix was tested during three consecutive cycles without regeneration steps, obtaining similar purification factors along the three cycles. Both matrices showed excellent and similar adsorption efficiency, exceeding 97%. The elution was optimized using a mixture of 25% ethylene glycol + 2 M NaCl at pH 7.0. These tests showed that the S-Y matrix had higher elution and yield than S-R with a range of elution percentages during three consecutive cycles between 44.9–63.3 for S-R and between 60.2–71.7 for S-Y. The same behavior and pattern of contaminants were observed in the analysis of the eluates by SDS-PAGE (Figure 3). The purity of the recovered LF was over 90% for both matrices. This approach, based on a low-cost ligand, showed an efficient performance for the recovery and purification of LF directly from whey, with a yield of 71% and a purification factor of 61 for S-Y and a yield of 62% and a purification factor of 52 for S-R [27].
Based on these results and the previously mentioned limitations of membrane systems, and considering the observations of Fee and Chand [17], our group opted for chitosan mini-sphere-based systems as chromatographic support to use for direct protein purification. Although the dyes immobilized on commercial Sepharose resins showed adequate performance, their use at scale, whether in dynamic or batch mode, becomes operationally complex and direct processing of the whey is not possible, requiring prior clarification stages. Chitosan mini-spheres are low-cost, widely available, biocompatible, biodegradable, and environmentally friendly [38,39]. Previous research in our laboratory had already demonstrated the chromatographic utility of these supports, specifically in the batch purification of wheat germ lectin from crude plant extracts [40]. That study showed that these mini-spheres facilitate the direct processing of crude samples, as they can be easily recovered from the medium through a simple sieving process, eliminating the need for centrifugation, due to their large size (approximately 1.76 mm). Furthermore, due to their differential density relative to the medium, the resins exhibit rapid and spontaneous sedimentation. Additionally, through simple chemical modifications, such as crosslinking with epichlorohydrin, we have enhanced their mechanical strength to resist multiple operational cycles and standard sanitation conditions.
Based on these results, further research evaluated the performance of a different dye immobilized on chitosan mini-spheres, compared to Red HE-3B, in identifying superior ligands [24]. To this end, chitosan mini-spheres were synthesized by the acid-base coacervation technique and chemically cross-linked with epichlorohydrin to enhance their mechanical and chemical stability, followed by the covalent immobilization of the two dyes (Red HE-3B and Yellow HE-4R). The synthesized matrices showed a homogeneous interconnected macroporous structure with an absence of agglomerations (Figure 4). Ligand density is a critical factor that directly influences the binding capacity of matrix. The dye density in the chitosan matrices showed a similar trend to that of Sepharose. Matrices with the Red HE-3B dye achieved greater ligand incorporation than matrices with Yellow HE-4R (7.3–8.4 µmol/g and 2.9–4.2 µmol/g, respectively). The parameters calculated according to the Langmuir model show maximum adsorption capacities of 51.1–58.3 mg/g for the chitosan matrix with Yellow dye and 40.2–51.0 mg/g for the matrix with Red dye. It should be noted that these values were higher than those obtained for each of the dyes on the Sepharose support (40.2 mg/g for S-Y and 27.8 mg/g for S-R). During the optimization process, these chitosan mini-spheres were evaluated against commercial agarose supports modified with the same dyes (Sepharose 4B). The results demonstrated that Yellow HE-4R immobilized on the chitosan matrix exhibited the best performance. The mini-spheres effectively adsorbed around 96% of the LF present in sweet whey within 1 h of contact, and over 80% of the adsorbed LF was eluted. A notable achievement was a yield of 77% with purity greater than 90% in a single purification step (Figure 5). Furthermore, the process proved efficient for multiple consecutive cycles without regeneration, highlighting its robustness and potential for industrial application. The overall yield and purification factor of the purification process were similar in three successive cycles of reuse, and the integrity of the chitosan matrix was not affected. After these cycles, matrices were regenerated with 50 mM NaOH, a new purification process was done, and the parameters of the first cycle were reached. An important characteristic of this matrix is that it can be used without the need to pre-condition the whey (modification of ionic strength, diafiltration) [24].
As a noteworthy extension of this study, Urtasun et al. (2013) described a study focused on the selection of triazine dyes as affinity ligands for the purification of recombinant bovine lactoferricin (Lfcin) [32]. Lfcin is a cationic peptide naturally generated through the acid hydrolysis of LF by gastric pepsin, which releases an N-terminal domain fragment with significantly greater biological activity than the intact protein. Due to its potent antimicrobial, antifungal, antiviral, and antitumor properties, this peptide has gained increasing biotechnological relevance as a high-value therapeutic agent. The challenge lies in efficiently purifying Lfcin, often expressed at low concentrations, from complex fermentation cultures. In this study, due to the low molecular weight of the intended Lfcin, three main constructs were designed and tested using the baculovirus expression system in the Sf9 insect cells. The constructs tested were Lfcin-GST (Lfcin expressed as a fusion protein with Glutathione S-transferase), BacGST (GST control), and BacLfcin (basal control). The study identified specific dyes that exhibited strong and selective binding interactions with the target peptide using SPR (surface plasmon resonance) technology as screening methodology. Five triazine dyes (Reactive Green 19, Red F5B, Red HE-3B, Cibacron Blue F3GA, and Yellow HE-4R) were tested. The dissociation constant results showed that the Yellow HE-4R dye exhibited a value on the order of magnitude of the Lfcin concentration in the culture medium. These findings were then applied to demonstrate the effectiveness of the selected dye-ligands in purifying recombinant Lfcin produced on the baculovirus system using affinity chromatography. For purification assays, the two selected dyes (Yellow HE-4R and Red HE-3B) were immobilized on a Sepharose 4B matrix (S-Y and S-R, respectively) and directly evaluated with the culture supernatant. The S-Y matrix showed an adsorption of 67.7 ± 1.8%, while the S-R matrix reached 74.9 ± 1.9% of BacLfcin. However, Western blot analysis indicated that the adsorption of the fusion protein Lfcin-GST was close to 100% on both matrices. Furthermore, Yellow HE-4R was found to be specific for Lfcin, while Red HE-3B interacted with both fractions of the recombinant protein. Regarding elution, the S-Y matrix showed the best elution rate, with 83.42 ± 0.29% of the adsorbed protein. The results indicated that Yellow HE-4R could efficiently capture Lfcin, leading to its successful isolation and purification. The study concluded that the Lfcin-GST construct yielded 10 mg/L of fusion protein (equivalent to 1.1 mg/L of pure Lfcin) at 96 h post-infection. Interestingly, this study also demonstrated that the optimal elution conditions for Lfcin (free and conjugated) were the same as those required to elute LF from cheese whey. The optimum was 2 M NaCl + 25% ethylene glycol. This indicates that Lfcin, or a portion thereof, is the LF component involved in the interaction with the dye.
On the other hand, our group has also made significant strides in the purification of lactoperoxidase, often using similar dye-affinity approaches. A novel process for bovine lactoperoxidase purification from sweet whey was described using dye-affinity chromatography [25]. This study involved screening 18 different triazine dyes immobilized on Sepharose 6B with sweet whey without pre-treatment. Five dye-Sepharose matrices showed over 90% LP adsorption directly from whey (Reactive Red 4, Orange R-HE, Blue R-HE, Yellow HE-4R, and Red HE-3B) [25]. The adsorption was evaluated under different ionic strengths. All selected matrices showed optimal adsorption in 20 mM sodium phosphate buffer, pH 7.0, with or without the addition of 0.15 M NaCl. Adsorption decreased significantly when the NaCl concentration increased to 0.5 M. Whey processed using the reactive Red 4-sepharose matrix in batch mode showed the highest LP purification yield (88%) and relative purity over 80% according to SDS-PAGE gel densitometry. It is worth mentioning that ~90% adsorption was achieved in 30 min, completing the process (~98%) after 180 min of contact with the serum. Under these conditions, low levels of LF (<0.5% of the original LF concentration) were co-purified [25]. This systematic approach to ligand selection is crucial for optimizing purification performance. Otherwise, purification of LP from whey using packed bed column mode with the reactive Red 4-sepharose matrix using a working flow of 1 mL/min showed lower yields (64%), and additional whey pretreatments were needed for dynamic processing. These pretreatments (thermocalcic precipitation, centrifugation and filtration) were necessary to remove fat and prevent column clogging and increased backpressure.
In a subsequent phase, the simultaneous adsorption of LF and LP proteins onto the same dye-affinity matrix, followed by their differential elution, was investigated [34]. This approach was similar to ion-exchange chromatography but aims to co-adsorb the two target proteins while minimizing cross-contamination between them during the elution. This research also investigated the use of chitosan mini-spheres with an immobilized dye to purify LP and LF from dairy whey. Through the synthesis and characterization of these materials, this study focused on establishing a foundation for the development of an integrated and highly efficient process for the simultaneous separation of both high-value proteins.
This could lower operating costs and improve overall product recovery. A screening of eleven immobilized dyes on chitosan mini-spheres identified Orange R-HE as the most effective ligand for the co-adsorption of both proteins. This matrix was characterized and utilized for LP and LF purification using a single-step direct adsorption and a two-step elution process, with minimal cross-contamination [34]. Moreover, mechanical characterizations were also conducted to comprehend and improve the usage cycles of the mini- spheres. Compressive strength and stiffness were measured to evaluate the changes in material hardness after the addition of the cross-linking agent (epichlorohydrin) and the dye as ligand (Figure 6A). Stiffness increased in direct proportion to the concentration of epichlorohydrin added, but when Orange R-HE was immobilized, stiffness decreased, suggesting that the dye alters the three-dimensional network of the hydrogel. Despite this reduction, the stiffness remains sufficient to ensure that the matrix does not undergo excessive deformation during processing. Furthermore, the elastic behavior of the matrices was evaluated (Figure 6B). The matrices showed primarily elastic/viscoelastic behavior at low cross-linker concentrations, regaining their shape without damage after ten cycles. In contrast, at the highest cross-linker concentration, the high rigidity led to irreversible plastic deformation. However, this behavior was improved by the dye addition, enabling the structural network to reorganize following compression. On the other hand, the Langmuir isotherm model was used to characterize the interaction between LP and LF and the matrix, yielding Qmax values of 56 mg/g for LF and 77 mg/g for LP. Adsorption studies showed that the interaction of LP with chitosan mini-spheres-Orange R-HE was partially influenced by ionic strength, whereas LF adsorption was not significantly affected. These results revealed the importance and differences in both electrostatic and hydrophobic interactions between LP and LF and the matrix [34]. Direct adsorption was possible even in the presence of 0.15 M NaCl. To maximize differential elution conditions and reduce cross-contamination between LP and LF, Response Surface Methodology (RSM) was employed [34]. A Box–Behnken experiment was selected for the elution study, considering three independent factors at three levels each (pH 3.0–9.0, NaCl molar concentration 0–2 M, and propylene glycol concentration 0–50%). The design required a total of 16 runs per block, including four center points to assess reproducibility. To minimize cross-contamination between the two proteins, an optimized response was defined that aimed to maximize selective elution and the purification factor. The elution process confirmed the multimodal nature of the interactions. A higher salt concentration (2 M NaCl) supplemented with 50% propylene glycol was needed for the elution of LF, whereas LP was successfully recovered by raising the pH and ionic strength (1 M NaCl). After three consecutive purification cycles, two separate products (LP and LF) with good yields (≈70% for LP and ≈60% for LF) and high purity, with minimal cross-contamination, could be obtained using a single-step direct adsorption process from sweet whey and a two-step differential elution process [34]. As previously mentioned, if these two high-value proteins could be directly recovered without the need for sweet whey pretreatments, yield could be raised and operating costs could be reduced. The impact of chemical modifications on the mechanical properties of chitosan was another important topic covered in that study. It was demonstrated that the covalent binding of the dye to the chitosan matrix increases both its stiffness, as measured by Young’s modulus, and its elastic recovery. These findings are critical when evaluating the material’s suitability for large-scale production and its durability over multiple operational cycles.

3.2. Co-Purification of Lactoferrin and Lactoperoxidase Using Ion Exchange Chromatography

Given the regulatory constraints regarding the use of triazine dyes as chromatographic ligands for some specific uses of the proteins, such as ingredients for infant food formulas, our group also explored cation-exchange chromatography for LF and LP purification [41]. As mentioned, both proteins have similar molecular weights and a basic isoelectric point. Ion-exchange chromatography is the reference chromatographic technique for purifying these proteins, in which both are co-adsorbed and sequentially eluted by increasing ionic strength. Generally, LP elutes in salt concentrations in the range of 0.2–0.5 M, while LF elutes require increasing the salt concentration to up to 1 M [28]. In these cases, a proportion of LF often co-elutes with LP, and cross-contamination levels can reach 40–50%.
To this end, a strategy was developed utilizing sulfanilic acid as a functional ligand, immobilized onto the previously described chitosan mini-spheres. Sulfanilic acid has interesting properties such as its zwitterionic characteristics and has already been explored as potential ligand [42].
The work presented in Hirsch et al. (2020) also builds upon previous work with chitosan mini-spheres [33]. In this study, an integrated process for cheese whey valorization was developed. It uses an anion-exchange matrix with glycidyltrimethylammonium as a ligand to recover WPI after direct capture of LF and LP using a cation-exchange matrix functionalized with sulfanilic acid. Chitosan mini-spheres, with an approximate diameter of 1.32 ± 0.14 mm, were activated with epichlorohydrin treatment and subsequently modified with sulfanilic acid. The matrix was characterized, and it was determined that the interaction was not purely ion exchange but multimodal, with a maximum adsorption capacity for pure lactoferrin of 112.4 ± 6.3 mg/g at pH 8.0. Furthermore, it was determined that the best adsorption condition was achieved using 100 mg of hydrated matrix per mL of whey, with a contact time of 4 h. To overcome the multimodal interactions (ionic and hydrophobic), the process was optimized using RSM to maximize capture and purification directly from sweet cheese whey. Under the optimized conditions, a purification yield of 68% was achieved, with a purity level of 70% for lactoferrin. The platform shows the potential for integrated processes, even though its primary focus is on LF purification and WPI recovery.
A more comprehensive approach to whey valorization is suggested by the capacity to recover WPI in addition to LF. The utility and adaptability of the synthesized chitosan-based resins for multi-product recovery were shown, despite the fact that effective separation of LP was not accomplished with these matrices [33]. Probably, the high particle size attempts against matrix resolution and sequential elution steps to obtain both proteins were not possible to apply. The method successfully separated LF with good purity and recovery yield, demonstrating that chitosan-based materials are a practical and cost-effective alternative to traditional commercial resins in LF purification. The stability of this developed matrix is one of its main benefits. Because the mini-spheres can be regenerated and used again for multiple adsorption–desorption cycles without experiencing a significant loss of capacity.

4. Conclusions

Through the years, our group has focused on providing cost-effective solutions for the valorization of cheese whey, demonstrating the technical feasibility of recovering and isolating high-value bioactive proteins. Furthermore, our contribution extends beyond process development to the design of the associated chromatographic matrices, the most expensive and critical consumables in the purification cycle. The exploration of novel matrices, such as chitosan mini-spheres and grafted polysulfone hollow fiber membranes, has led to improved adsorption capacities and purification efficiencies compared to traditional matrices like agarose beads. The successful utilization of various triazine dyes (Yellow HE-4R, Red HE-3B, reactive Red 4) as affinity ligands demonstrates a viable and economical alternative to more expensive affinity biological ligands.
The achieved yields and purification factors highlight the effectiveness of the developed methods in isolating target proteins directly from complex whey mixtures in a single step.
Despite these advantages, some limitations should be acknowledged. The use of synthetic triazine dyes may pose regulatory constraints for certain applications, such as infant formula production [41], and the scale-up of novel supports can present challenges related to stability and process performance. In addition, alternative technologies such as ion-exchange chromatography or expanded bed adsorption may offer more standardized industrial implementation, although they often require additional pre-treatment steps. These aspects highlight the need to balance selectivity, scalability, and regulatory considerations when designing purification strategies.
Future directions could focus on further optimizing the binding and elution conditions for simultaneous purification of LF and LP, exploring continuous chromatographic systems for industrial scale-up. The continued innovation in affinity chromatography, particularly with cost-effective and versatile ligands and matrices, holds immense promise for maximizing the value of dairy whey and contributing to a more sustainable dairy industry.

5. Future Perspective

The research group continues its work on whey, with a future focus on its comprehensive valorization. The emphasis is on developing sequential processes that allow for the initial capture and purification of LF and LP (high-value, low-concentration proteins), followed by the recovery and purification of major proteins (β-LG, α-LA, and GMP) or the production of whey protein concentrates or isolates (WPC/WPI).
Future work will focus on two approaches. First, the use of chromatographic matrices such as modified chitosan mini-spheres that allow for the direct processing of raw whey, eliminating costly pretreatments. After the extraction of LF and LP, the remaining whey can be subjected to ultrafiltration or anion-exchange chromatography to recover the major fractions, ensuring that no valuable biological material is lost in the process. On the other hand, the development of purification trains using commercially available matrices for the sequential recovery of each fraction facilitates the technology transfer and implementation in the industry.
Implementing these comprehensive systems not only maximizes economic profitability by recovering both minor and major fractions but also meets growing environmental demands by reducing the ecological impact of whey waste. The development of single-step direct adsorption processes will remain key to achieving global competitiveness.

Author Contributions

Conceptualization, M.F.B.; validation, F.J.W.; formal analysis, M.F.B.; data curation, F.J.W.; writing—original draft preparation, M.F.B.; writing—review and editing, M.F.B., L.D.P., M.V.M. and F.J.W.; supervision, F.J.W.; funding acquisition, M.F.B. and F.J.W. All authors have read and agreed to the published version of the manuscript.

Funding

This research was funded by the Universidad de Buenos Aires, grant UBACYT 20020220200097BA and the Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET), grant PIBAA 2022–2023 N°0171.

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

The datasets used and/or analyzed during the current study are available from the corresponding author upon reasonable request.

Acknowledgments

During the preparation of this manuscript, the authors used Trinka AI (version 0.2, Crimson AI LLP, Mumbai, India) to check the grammar and improve the language quality of this manuscript. The authors have reviewed and edited the output and take full responsibility for the content of this publication.

Conflicts of Interest

The authors declare no conflicts of interest.

Abbreviations

The following abbreviations are used in this manuscript:
LFLactoferrin
LPLactoperoxidase
BLGβ-lactoglobulin
ALAα-lactalbumin
GMPGlycomacropeptide
IgsImmunoglobulins
BSABovine serum albumin
WPCWhey Protein Concentrate
WPIWhey Protein Isolate
pIIsoelectric point
QmaxMaximum capacity
SCN-Thiocyanate
SDS-PAGEPolyacrylamide gel electrophoresis with sodium dodecyl sulfate
GMAGlycidyl methacrylate
DMAADimethylacrylamide
ELISAEnzyme-linked immunosorbent assay
GSTGlutathione S-transferase
Lfcinbovine lactoferricin
CMSChitosan mini-spheres
SPRSurface plasmon resonance
RSMResponse Surface Methodology

References

  1. Chen, G.; Qu, Y.; Gras, S.; Kentish, S. Separation Technologies for Whey Protein Fractionation. Food Eng. Rev. 2023, 15, 438–465. [Google Scholar] [CrossRef]
  2. Pires, A.F.; Marnotes, N.G.; Rubio, O.D.; Garcia, A.C.; Pereira, C.D. Dairy By-Products: A Review on the Valorization of Whey and Second Cheese Whey. Foods 2021, 10, 1067. [Google Scholar] [CrossRef] [PubMed]
  3. Buchanan, D.; Martindale, W.; Romeih, E.; Hebishy, E. Recent Advances in Whey Processing and Valorisation: Technological and Environmental Perspectives. Int. J. Dairy Technol. 2023, 76, 291–312. [Google Scholar] [CrossRef]
  4. Kaur, N.; Sharma, P.; Jaimni, S.; Kehinde, B.; Kaur, S. Recent Developments in Purification Techniques and Industrial Applications for Whey Valorization: A Review. Chem. Eng. Commun. 2019, 207, 123–138. [Google Scholar] [CrossRef]
  5. Pedersen, L.; Mollerup, J.; Hansen, E.; Jungbauer, A. Whey Proteins as a Model System for Chromatographic Separation of Proteins. J. Chromatogr. B 2003, 790, 161–173. [Google Scholar] [CrossRef] [PubMed]
  6. Fee, C.J.; Chand, A. Capture of Lactoferrin and Lactoperoxidase from Raw Whole Milk by Cation Exchange Chromatography. Sep. Purif. Technol. 2006, 48, 143–149. [Google Scholar] [CrossRef]
  7. Pilbrow, J.; Bekhit, A.E.D.A.; Carne, A. Fractionation of Sheep Cheese Whey by a Scalable Method to Sequentially Isolate Bioactive Proteins. Food Chem. 2016, 203, 165–174. [Google Scholar] [CrossRef] [PubMed]
  8. Faraji, N.; Zhang, Y.; Ray, A.K. Optimization of Lactoperoxidase and Lactoferrin Separation on an Ion-Exchange Chromatography Step. Separations 2017, 4, 10. [Google Scholar] [CrossRef]
  9. Zhang, Y.; Lu, C.; Zhang, J. Lactoferrin and Its Detection Methods: A Review. Nutrients 2021, 13, 2492. [Google Scholar] [CrossRef] [PubMed]
  10. Ulber, R.; Plate, K.; Weiss, T.; Demmer, W.; Buchholz, H.; Scheper, T. Downstream Processing of Bovine Lactoferrin from Sweet Whey. Acta Biotechnol. 2001, 21, 27–34. [Google Scholar] [CrossRef]
  11. Bosco, F.; Mollea, C.; Marmo, L. Valorisation of Cheese Whey, a By-Product from the Dairy Industry. In Food Industry; Muzzalupo, I., Ed.; IntechOpen: London, UK, 2013; Volume 24, pp. 549–588. [Google Scholar]
  12. Liang, Y.; Wang, X.; Wu, M.; Zhu, W. Simultaneous Isolation of Lactoferrin and Lactoperoxidase from Bovine Colostrum by SPEC 70 SLS Cation Exchange Resin. Int. J. Environ. Res. Public Health 2011, 8, 3764–3776. [Google Scholar] [CrossRef] [PubMed]
  13. Özhan, H.K.; Duman, H.; Bechelany, M.; Karav, S. Lactoperoxidase: Properties, Functions, and Potential Applications. Int. J. Mol. Sci. 2025, 26, 5055. [Google Scholar] [CrossRef] [PubMed]
  14. Sukmana, H.; Rizwana, I.; Dobozi, R.; Al-Tayawi, A.N.; Szabó, B.P.; Özer, B.; Kertész, S. A Review of Various Protein Separation Techniques and Valorization of Cheese Whey and Buttermilk. Eur. Food Res. Technol. 2025, 251, 4263–4279. [Google Scholar] [CrossRef]
  15. Silva, E.; Oliveira, J.; Silva, Y.; Urbano, S.; Sales, D.; Moraes, E.; Rangel, A.; Anaya, K. Lactoperoxidase System in the Dairy Industry: Challenges and Opportunities. Czech J. Food Sci. 2020, 38, 337–346. [Google Scholar] [CrossRef]
  16. Urtasun, N.; Baieli, M.F.; Hirsch, D.; Miranda, M.V.; Cascone, O.; Wolman, F.J. Challenges in Dairy Whey Protein Purification. In Handbook on Protein Purification: Industry Challenges and Technological Developments; Labrou, N.E., Chronopoulou, E.G., Eds.; Nova Science Publishers: Hauppauge, NY, USA, 2018; pp. 105–126. ISBN 9781536143669. [Google Scholar]
  17. Fee, C.J.; Chand, A. Design Considerations for the Batch Capture of Proteins from Raw Whole Milk by Ion Exchange Chromatography. Chem. Eng. Technol. 2005, 28, 1360–1366. [Google Scholar] [CrossRef]
  18. El-Sayed, M.; Chase, H. Trends in Whey Protein Fractionation. Biotechnol. Lett. 2011, 33, 1501–1511. [Google Scholar] [CrossRef] [PubMed]
  19. Du, Q.-Y.; Lin, D.-Q.; Xiong, Z.-S.; Yao, S.-J. One-Step Purification of Lactoferrin from Crude Sweet Whey Using Cation-Exchange Expanded Bed Adsorption. Ind. Eng. Chem. Res. 2013, 52, 2693–2699. [Google Scholar] [CrossRef]
  20. El-Sayed, M.; Chase, H. Purification of the Two Major Proteins from Whey Concentrate Using a Cation-Exchange Selective Adsorption Process. Biotechnol. Prog. 2009, 26, 192–199. [Google Scholar] [CrossRef] [PubMed]
  21. Pan, M.; Shen, S.; Chen, L.; Dai, B.; Xu, L.; Yun, J.; Yao, K.; Lin, D.Q.; Yao, S.J. Separation of Lactoperoxidase from Bovine Whey Milk by Cation Exchange Composite Cryogel Embedded Macroporous Cellulose Beads. Sep. Purif. Technol. 2015, 147, 132–138. [Google Scholar] [CrossRef]
  22. Gurgel, P.V.; Carbonell, R.G.; Swaisgood, H.E. Fractionation of Whey Proteins with a Hexapeptide Ligand Affinity Resin. Bioseparation 2000, 9, 385–392. [Google Scholar] [CrossRef] [PubMed]
  23. Besselink, T.; Janssen, A.E.M.; Boom, R.M. Isolation of Bovine Serum Albumin from Whey Using Affinity Chromatography. Int. Dairy J. 2015, 41, 32–37. [Google Scholar] [CrossRef]
  24. Baieli, M.F.; Urtasun, N.; Miranda, M.V.; Cascone, O.; Wolman, F.J. Isolation of Lactoferrin from Whey by Dye-Affinity Chromatography with Yellow HE-4R Attached to Chitosan Mini-Spheres. Int. Dairy J. 2014, 39, 53–59. [Google Scholar] [CrossRef]
  25. Urtasun, N.; Baieli, M.F.; Hirsch, D.B.; Martínez-Ceron, M.C.; Cascone, O.; Wolman, F.J. Lactoperoxidase Purification from Whey by Using Dye Affinity Chromatography. Food Bioprod. Process. 2017, 103, 58–65. [Google Scholar] [CrossRef]
  26. Rodriguez, E.L.; Poddar, S.; Iftekhar, S.; Suh, K.; Woolfork, A.G.; Ovbude, S.; Pekarek, A.; Walters, M.; Lott, S.; Hage, D.S. Affinity Chromatography: A Review of Trends and Developments over the Past 50 Years. J. Chromatogr. B 2020, 1157, 122332. [Google Scholar] [CrossRef] [PubMed]
  27. Baieli, M.F.; Urtasun, N.; Miranda, M.V.; Cascone, O.; Wolman, F.J. Bovine Lactoferrin Purification from Whey Using Yellow HE-4R as the Chromatographic Affinity Ligand. J. Sep. Sci. 2014, 37, 484–487. [Google Scholar] [CrossRef] [PubMed]
  28. Plate, K.; Beutel, S.; Buchholz, H.; Demmer, W.; Fischer-Frühholz, S.; Reif, O.; Ulber, R.; Scheper, T. Isolation of Bovine Lactoferrin, Lactoperoxidase and Enzymatically Prepared Lactoferricin from Proteolytic Digestion of Bovine Lactoferrin Using Adsorptive Membrane Chromatography. J. Chromatogr. A 2006, 1117, 81–86. [Google Scholar] [CrossRef] [PubMed]
  29. Nath, A.; Zin, M.M.; Molnár, M.A.; Bánvölgyi, S.; Gáspár, I.; Vatai, G.; Koris, A. Membrane Chromatography and Fractionation of Proteins from Whey—A Review. Processes 2022, 10, 1025. [Google Scholar] [CrossRef]
  30. Grasselli, M.; Cascone, O. Separation of Lactoferrin from Bovine Whey by Dye Affinity Chromatography. Neth. Milk Dairy J. 1996, 50, 551–561. [Google Scholar]
  31. Wolman, F.J.; González Maglio, D.; Grasselli, M.; Cascone, O. One-Step Lactoferrin Purification from Bovine Whey and Colostrum by Affinity Membrane Chromatography. J. Memb. Sci. 2007, 288, 132–138. [Google Scholar] [CrossRef]
  32. Urtasun, N.; Baieli, M.F.; Romasanta, P.N.; Fernández, M.M.; Malchiodi, E.L.; Cascone, O.; Wolman, F.J.; Miranda, M.V. Triazinic Dye Ligand Selection by Surface Plasmon Resonance for Recombinant Lactoferricin Purification. Process Biochem. 2013, 48, 1972–1979. [Google Scholar] [CrossRef]
  33. Hirsch, D.B.; Martínez Álvarez, L.M.; Urtasun, N.; Baieli, M.F.; Lázaro-Martínez, J.M.; Glisoni, R.J.; Miranda, M.V.; Cascone, O.; Wolman, F.J. Lactoferrin Purification and Whey Protein Isolate Recovery from Cheese Whey Using Chitosan Mini-Spheres. Int. Dairy J. 2020, 109, 104764. [Google Scholar] [CrossRef]
  34. Urtasun, N.; Mignon, A.; Martínez-Alvarez, L.M.; Baieli, M.F.; Hirsch, D.B.; Cascone, O.; Dubruel, P.; Wolman, F.J. Synthesis and Characterization of Chitosan Mini-Spheres with Immobilized Dye as Affinity Ligand for the Purification of Lactoperoxidase and Lactoferrin from Dairy Whey. Sep. Purif. Technol. 2021, 255, 117700. [Google Scholar] [CrossRef]
  35. Liu, J.-M.; Liu, C.-C.; Fang, G.-Z.; Wang, S. Advanced Analytical Methods and Sample Preparation for Ion Chromatography Techniques. RSC Adv. 2015, 5, 58713–58726. [Google Scholar] [CrossRef]
  36. Bhut, B.V.; Christensen, K.A.; Husson, S.M. Membrane Chromatography: Protein Purification from E. Coli Lysate Using Newly Designed and Commercial Anion-Exchange Stationary Phases. J. Chromatogr. A 2010, 1217, 4946–4957. [Google Scholar] [CrossRef] [PubMed]
  37. Liu, H.F.; Ma, J.; Winter, C.; Bayer, R. Recovery and Purification Process Development for Monoclonal Antibody Production. MAbs 2010, 2, 480–499. [Google Scholar] [CrossRef] [PubMed]
  38. Olunusi, S.O.; Ramli, N.H.; Adam, F.; Hossain, E.; Kim, T.H. Chitosan as a Sustainable Alternative for Fresh Food Packaging: Structural Insights, Modification Strategies, and Innovations for Commercial Viability. Int. J. Biol. Macromol. 2025, 318, 145065. [Google Scholar] [CrossRef] [PubMed]
  39. Hameed, A.Z.; Raj, S.A.; Kandasamy, J.; Baghdadi, M.A.; Shahzad, M.A. Chitosan: A Sustainable Material for Multifarious Applications. Polymers 2022, 14, 2335. [Google Scholar] [CrossRef] [PubMed]
  40. Baieli, M.F.; Urtasun, N.; Miranda, M.V.; Cascone, O.; Wolman, F.J. Efficient Wheat Germ Agglutinin Purification with a Chitosan-Based Affinity Chromatographic Matrix. J. Sep. Sci. 2012, 35, 231–238. [Google Scholar] [CrossRef] [PubMed]
  41. U.S. Food and Drug Administration (FDA). Guidance for Industry: Preparation of Food Contact Notifications for Food Contact Substances in Contact with Infant Formula and/or Human Milk; U.S. Department of Health and Human Services: Silver Spring, MD, USA, 2019. Available online: https://www.fda.gov/regulatory-information/search-fda-guidance-documents/guidance-industry-preparation-food-contact-notifications-food-contact-substances-contact-infant (accessed on 26 May 2026).
  42. Krokhin, O.V.; Obrezkov, O.N.; Shpigun, O.A. Use of aromatic sulfonic acids as eluents in ion chromatography. J. Anal. Chem. 1993, 48, 1180–1185. [Google Scholar]
Figure 1. Isotherms for LF adsorption on Red HE-3B/Sepharose 4B (■), Red HE-3B/GMA membranes (♦) and Red HE-3B/GMA-DMAA membranes (●). c*: LF equilibrium concentration in the supernatant. q*: LF equilibrium concentration bound to the membrane per unit of total membrane volume. Reproduced with permission from Wolman et al., J. Memb. Sci, 2007 [31].
Figure 1. Isotherms for LF adsorption on Red HE-3B/Sepharose 4B (■), Red HE-3B/GMA membranes (♦) and Red HE-3B/GMA-DMAA membranes (●). c*: LF equilibrium concentration in the supernatant. q*: LF equilibrium concentration bound to the membrane per unit of total membrane volume. Reproduced with permission from Wolman et al., J. Memb. Sci, 2007 [31].
Jpbi 03 00016 g001
Figure 2. LF purification pattern obtained with Red HE-3B/Sepharose 4B at a flow rate of 0.4 mL/min (A) and with Red HE-3B/GMA-DMAA membranes at 0.4 mL/min (B); at 5.0 mL/min (C); at 5 mL/min (D) for the load, wash, and regeneration steps and 0.4 mL/min for the elution step. The first arrow indicates the change to elution buffer; the second arrow indicates the change to regeneration buffer. (- - -) LF concentration determined by ELISA. (-●-) Absorbance at 280 nm. Reproduced with permission from Wolman et. al, J. Memb. Sci, 2007 [31].
Figure 2. LF purification pattern obtained with Red HE-3B/Sepharose 4B at a flow rate of 0.4 mL/min (A) and with Red HE-3B/GMA-DMAA membranes at 0.4 mL/min (B); at 5.0 mL/min (C); at 5 mL/min (D) for the load, wash, and regeneration steps and 0.4 mL/min for the elution step. The first arrow indicates the change to elution buffer; the second arrow indicates the change to regeneration buffer. (- - -) LF concentration determined by ELISA. (-●-) Absorbance at 280 nm. Reproduced with permission from Wolman et. al, J. Memb. Sci, 2007 [31].
Jpbi 03 00016 g002
Figure 3. SDS-PAGE analysis of the purification process during three consecutive cycles using the Sepharose-Yellow HE-4R matrix. Lane 1, molecular weight markers; lane 2, bovine whey; lanes 3–5, supernatant after adsorption in cycles 1, 2 and 3, respectively; lanes 6–8, eluate in cycles 1, 2 and 3, respectively; lane 9, standard bovine lactoferrin (2 mg/mL). Reproduced with permission from Baieli et al., J. Sep. Sci., 2014 [27].
Figure 3. SDS-PAGE analysis of the purification process during three consecutive cycles using the Sepharose-Yellow HE-4R matrix. Lane 1, molecular weight markers; lane 2, bovine whey; lanes 3–5, supernatant after adsorption in cycles 1, 2 and 3, respectively; lanes 6–8, eluate in cycles 1, 2 and 3, respectively; lane 9, standard bovine lactoferrin (2 mg/mL). Reproduced with permission from Baieli et al., J. Sep. Sci., 2014 [27].
Jpbi 03 00016 g003
Figure 4. Scanning electron microscopy image of chitosan matrix before cross-linking and dye coupling. Reproduced with permission from Baieli et. al., Int. Dairy J., 2014 [24].
Figure 4. Scanning electron microscopy image of chitosan matrix before cross-linking and dye coupling. Reproduced with permission from Baieli et. al., Int. Dairy J., 2014 [24].
Jpbi 03 00016 g004
Figure 5. SDS-PAGE of the lactoferrin (Lf) purification process using a chitosan matrix cross-linked with 500 mM epichlorohydrin coupled to Yellow HE-4R during three purification cycles: lane 1, protein ladder; lane 2, whey; lane 3–5, supernatant after adsorption from cycles 1, 2 and 3, respectively; lane 6–8, eluate from cycles 1, 2 and 3, respectively; lane 9, commercial Lf (2 mg/mL). Reproduced with permission from Baieli et. al., Int. Dairy J., 2014 [24].
Figure 5. SDS-PAGE of the lactoferrin (Lf) purification process using a chitosan matrix cross-linked with 500 mM epichlorohydrin coupled to Yellow HE-4R during three purification cycles: lane 1, protein ladder; lane 2, whey; lane 3–5, supernatant after adsorption from cycles 1, 2 and 3, respectively; lane 6–8, eluate from cycles 1, 2 and 3, respectively; lane 9, commercial Lf (2 mg/mL). Reproduced with permission from Baieli et. al., Int. Dairy J., 2014 [24].
Jpbi 03 00016 g005
Figure 6. Mechanical characterization of chitosan mini-spheres. Mini-spheres cross-linking with different ratios of epichlorohydrin (equivalents): 0.0 (Jpbi 03 00016 i001), 1.0 (Jpbi 03 00016 i002), 2.5 (Jpbi 03 00016 i003), 5.0 (Jpbi 03 00016 i004) and 5.0 + Orange R-HE (Jpbi 03 00016 i005). (A) Determination of compression modulus and (B) Compression–relaxation cycles. Different letters represent significant differences among media (p < 0.05). Reproduced with permission from Urtasun et. al., Sep. Purif. Technol., 2021 [34].
Figure 6. Mechanical characterization of chitosan mini-spheres. Mini-spheres cross-linking with different ratios of epichlorohydrin (equivalents): 0.0 (Jpbi 03 00016 i001), 1.0 (Jpbi 03 00016 i002), 2.5 (Jpbi 03 00016 i003), 5.0 (Jpbi 03 00016 i004) and 5.0 + Orange R-HE (Jpbi 03 00016 i005). (A) Determination of compression modulus and (B) Compression–relaxation cycles. Different letters represent significant differences among media (p < 0.05). Reproduced with permission from Urtasun et. al., Sep. Purif. Technol., 2021 [34].
Jpbi 03 00016 g006
Table 1. Summaries of the LF and LP purification methods carried out by Dr. Cascone’s research group.
Table 1. Summaries of the LF and LP purification methods carried out by Dr. Cascone’s research group.
ReferenceMatrixTarget ProteinYield (%) aPurity (%)
Grasselli, et al. 1996 [30]Sepharose—Red HE-3BLF8290
Wolman, et al. 2007 [31]Hollow fiber membrane—Red HE-3BLF9094
Agarose—Red HE-3BLF4580
Urtasun, et al. 2013 [32]Sepharose—Yellow HE-4RLfcin57 b>90
Baieli, et al. 2014 [24]Chitosan mini-spheres—Yellow HE-4RLF77>90
Baieli, et al. 2014 [27]Sepharose—Yellow HE-4RLF71>90
Sepharose—Red HE-3BLF62>90
Urtasun, et al. 2017 [25]Sepharose—Reactive Red 4 (batch mode)LP88>80
Sepharose—Reactive Red 4 (column mode)LP64>60
Hirsch, et al. 2020 [33]Chitosan mini-spheres—sulfanilic acidLF6870
Urtasun, et al. 2021 [34]Chitosan mini-spheres—Orange R-HELP70High
LF60High
a Yield = recovery mass of LF (or LP)/initial mass of LF (or LP) × 100. b Calculated from the adsorption and elution data reported in the original study for comparative purposes using the equation: Yield = (Adsorption % × Elution %)/100.
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Baieli, M.F.; Pilato, L.D.; Miranda, M.V.; Wolman, F.J. Advances in the Purification of Lactoferrin and Lactoperoxidase from Dairy Whey. J. Pharm. BioTech Ind. 2026, 3, 16. https://doi.org/10.3390/jpbi3030016

AMA Style

Baieli MF, Pilato LD, Miranda MV, Wolman FJ. Advances in the Purification of Lactoferrin and Lactoperoxidase from Dairy Whey. Journal of Pharmaceutical and BioTech Industry. 2026; 3(3):16. https://doi.org/10.3390/jpbi3030016

Chicago/Turabian Style

Baieli, María F., Laura D. Pilato, María V. Miranda, and Federico J. Wolman. 2026. "Advances in the Purification of Lactoferrin and Lactoperoxidase from Dairy Whey" Journal of Pharmaceutical and BioTech Industry 3, no. 3: 16. https://doi.org/10.3390/jpbi3030016

APA Style

Baieli, M. F., Pilato, L. D., Miranda, M. V., & Wolman, F. J. (2026). Advances in the Purification of Lactoferrin and Lactoperoxidase from Dairy Whey. Journal of Pharmaceutical and BioTech Industry, 3(3), 16. https://doi.org/10.3390/jpbi3030016

Article Metrics

Back to TopTop